Search research articles
Contact Us
Filters
Showing results (801-810 of 838) with videos related to
Page
of 84
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 27, 2009
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation
Thomas J Nevill, John D Shepherd, Heather J Sutherland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2006
Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes
K W Song, M J Barnett, R D Gascoyne, et al.
Leukemia Research
|
September 3, 2008
Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels
Donna L Forrest, Shannon Trainor, Ryan R Brinkman, et al.
Blood
|
August 30, 2008
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy
Carolyn J Owen, Cynthia L Toze, Anna Koochin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 29, 2024
A randomized trial of behavioral interventions yielding sustained reductions in distracted driving
Jeffrey P Ebert, Ruiying A Xiong, Neda Khan, et al.
Blood
|
May 5, 2005
High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver
Julye C Lavoie, Joseph M Connors, Gordon L Phillips, et al.
Leukemia & Lymphoma
|
December 8, 2010
Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months)
Christopher P Venner, Joseph M Connors, Heather J Sutherland, et al.
Journal of the National Cancer Institute
|
March 1, 2013
Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex
Min Chen, Paolo Gallipoli, Donna DeGeer, et al.
Bone Marrow Transplantation
|
September 10, 2005
Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease
C L Toze, A Galal, M J Barnett, et al.
British Journal of Haematology
|
May 30, 2012
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort
Cynthia L Toze, Chinmay B Dalal, Thomas J Nevill, et al.
Page
of 84
Search research articles
Search
Showing results (801-810 of 838) with videos related to
Sort By:
Page
of 84
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 27, 2009
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation
Thomas J Nevill, John D Shepherd, Heather J Sutherland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2006
Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes
K W Song, M J Barnett, R D Gascoyne, et al.
Leukemia Research
|
September 3, 2008
Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels
Donna L Forrest, Shannon Trainor, Ryan R Brinkman, et al.
Blood
|
August 30, 2008
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy
Carolyn J Owen, Cynthia L Toze, Anna Koochin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 29, 2024
A randomized trial of behavioral interventions yielding sustained reductions in distracted driving
Jeffrey P Ebert, Ruiying A Xiong, Neda Khan, et al.
Blood
|
May 5, 2005
High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver
Julye C Lavoie, Joseph M Connors, Gordon L Phillips, et al.
Leukemia & Lymphoma
|
December 8, 2010
Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months)
Christopher P Venner, Joseph M Connors, Heather J Sutherland, et al.
Journal of the National Cancer Institute
|
March 1, 2013
Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex
Min Chen, Paolo Gallipoli, Donna DeGeer, et al.
Bone Marrow Transplantation
|
September 10, 2005
Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease
C L Toze, A Galal, M J Barnett, et al.
British Journal of Haematology
|
May 30, 2012
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort
Cynthia L Toze, Chinmay B Dalal, Thomas J Nevill, et al.
Page
of 84